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Obituary 809 Michael E. DeBakey, 1908 to 2008
Oscar Howard Frazier, MD, Houston, TX
Editorials 812 Mission Critical: Thoracic Surgery Education Reform
W. Randolph Chitwood, Jr, MD, Thomas L. Spray, MD, Richard H. Feins, MD, and
Michael J. Mack, MD, Greenville, NC
814 You Never Know Unless You Try
George L. Hicks, Jr, MD, John W. Brown, MD, John H. Calhoon, MD, and
Walter H. Merrill, MD, Chicago, Illinois
Expert Commentary 816 Fool me once, shame on you; fool me twice, shame on me! A perspective on the
emerging world of percutaneous heart valve therapy
Michael Mack, MD, Dallas, Tex
820 Energy loss for evaluating heart valve performance
Cary W. Akins, MD, Brandon Travis, PhD, and Ajit P. Yoganathan, PhD, Boston, Mass,
Denmark, and Atlanta, Ga
This review defines what energy loss is, how it is measured, and how it might be applied to clinical
situations of heart valve disease to better understand the impact of valvular disease on ventricular
function.
General Thoracic
Surgery (GTS)
834 The short esophagus: Intraoperative assessment of esophageal length
Sandro Mattioli, MD, Maria Luisa Lugaresi, MD, PhD, Mario Costantini, MD,
Alberto Del Genio, MD, Natale Di Martino, MD, Landino Fei, MD, Uberto Fumagalli, MD,
Vincenzo Maffettone, MD, Luigi Monaco, MD, Mario Morino, MD, Fabrizio Rebecchi, MD,
Riccardo Rosati, MD, Mauro Rossi, MD, Stefano Santi, MD, Vincenzo Trapani, MD,
and Giovanni Zaninotto, MD, Bologna, Padova, Naples, Milan, Turin, and Pisa, Italy
The distance between the EG junction localized by intraoperative endoscopy and the diaphragmatic
hiatus was measured in 180 patients undergoing antireflux surgery. After esophageal mediastinal
dissection, this distance was shorter than 1.5 cm in 18.8% of patients. Short esophagus is an important
issue in patients undergoing GERD surgery.
842 Expert commentary: A multicenter study to define the incidence of short
esophagus in surgical patients with gastroesophageal reflux disease
F. Griffith Pearson, MD, Mansfield, Ontario, Canada
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TX843 Autologous fibrin sealant reduces the incidence of prolonged air leak and
duration of chest tube drainage after lung volume reduction surgery:
A prospective randomized blinded study
C. Moser, MD, I. Opitz, MD, W. Zhai, MD, V. Rousson, MD, E. W. Russi, MD, W. Weder, MD,
and D. Lardinois, MD, Zurich, Switzerland
This prospective randomized study demonstrated that thoracoscopic application of autologous
sealant along the staple lines significantly reduces the incidence and the duration of prolonged air leak
as well as the duration of chest tube drainage after LVRS in patients with end-stage emphysema.
850 Intrathoracic esophageal replacement by in situ tissue-engineered esophagus
Yuen Nakase, MD, PhD, Tatsuo Nakamura, MD, PhD, Shuichi Kin, MD, PhD, Susumu Nakashima,
MD, PhD, Tetsuji Yoshikawa, MD, PhD, Yoshiaki Kuriu, MD, PhD, Chohei Sakakura, MD, PhD,
Hisakazu Yamagishi, MD, PhD, Junji Hamuro, PhD, Yoshito Ikada, PhD, Eigo Otsuji, MD, PhD,
and Akeo Hagiwara, MD, PhD, Nara and Kyoto, Japan
Partial intrathoracic esophageal replacement was successfully performed by using an in situ tissue-
engineered esophagus that showed well-differentiated, stratified squamous cells on its luminal
surface and contained thick smooth muscle tissue without any complication for 420 days. This
procedure may offer a promising surgical approach to esophageal diseases.
Surgery for Acquired
Cardiovascular Disease
(ACD)
860 Reoperative aortic root and transverse arch procedures: A comparison with
contemporaneous primary operations
Christian D. Etz, MD, Konstadinos A. Plestis, MD, Tobias M. Homann, MD, Carol A. Bodian, DrPH,
Gabriele Di Luozzo, MD, David Spielvogel, MD, and Randall B. Griepp, MD, New York, NY
When comparing reoperative (n 5 200) and contemporaneous primary (n 5 480) root/ascending
aorta and arch procedures, operative mortality was higher for reoperative (vs primary) root/ascending
aorta procedures (7% vs 3%, P 5 .07) but comparable for reoperative (vs primary) arch procedures
(9% vs 10%, P5 .97). The long-term outlook was better after root than after arch operations, with no
difference between primary and reoperative procedures.
868 Chordal translocation for ischemic mitral regurgitation may ameliorate
tethering of the posterior and anterior mitral leaflets
Shinji Masuyama, MD, Akira Marui, MD, PhD, Takeshi Shimamoto, MD, Michihito Nonaka, MD,
Miwako Tsukiji, MD, Nozomi Watanabe, MD, PhD, Tadashi Ikeda, MD, PhD, Kiyoshi Yoshida, MD,
PhD, and Masashi Komeda, MD, PhD, Kyoto and Kurashiki, Japan
Secondary chordal cutting ameliorates tethering of the anterior mitral leaflet, but not the posterior
mitral leaflet, and affects valvular-ventricular continuity. ‘‘Chordal translocation’’ is a novel
subvalvular approach that corrects both anterior and posterior tethering and maintains LV function.
We investigated its efficacy in a canine model of acute IMR.
876 Vascular adaptation of the internal thoracic artery graft early and late after
bypass surgery
Beat H. Walpoth, MD, Markus Schmid, MD, Anna Schwab, MD, Andreas Bosshard, MD, Friedrich
Eckstein, MD, Thierry Carrel, MD, and Otto M. Hess, MD, Geneva and Bern, Switzerland
Myocardial flow mismatch between the supplying artery and the myocardial perfusion region was
evaluated after internal thoracic artery grafting. We studied graft flow in 30 patients undergoing
coronary artery bypass grafting intraoperatively and 3 and 10 months postoperatively. A significantly
reduced internal thoracic artery flow and flow reserve was found intraoperatively, which normalized
postoperatively.
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TX884 Pexelizumab in ischemic heart disease: A systematic review and meta-analysis
on 15,196 patients
L. Testa, MD, PhD, FEAPCI, W. J. Van Gaal, MD, FRACP, R. Bhindi, MD, PhD, FESC, G. G. L.
Biondi-Zoccai, MD, A. Abbate, MD, P. Agostoni, MD, I. Porto, MD, F. Andreotti, MD, FESC,
F. Crea, MD, FESC, FACC, and A. P. Banning, MD, FESC, Oxford, United Kingdom, Richmond,
Va, Antwerp, Belgium, and Rome and Turin, Italy
Pexelizumab has been postulated to improve outcomes in patients undergoing CABG and urgent
reperfusion therapy for STEMI. We aimed at evaluating the risk/benefit profile of pexelizumab
(bolus 1 infusion) versus placebo. Electronic and manual searches of randomized controlled trials
have been done. No benefit of adding pexelizumab was found in the overall analysis for MAEs,
death, MI, stroke, heart failure, nor in the settings of patients with STEMI. Pexelizumab was
associated with a 26% reduction of the risk of death in the setting of CABG. The number needed to
treat was 100.
894 The influence of seasonal variation on cardiac surgery: A time-related clinical
outcome predictor
Jeffrey H. Shuhaiber, MD, Kimberley Goldsmith, MA, and Samer A. M. Nashef, FRCS,
Cambridge, United Kingdom
Cardiac surgery outcomes are influenced by the time of year. Over a 10 year period, we found that
coronary artery bypass grafting performed during the summer season had a lower risk-adjusted
mortality and shorter hospital stay than the winter season. Potential explanations for this new findings
are discussed further.
900 In situ tissue regeneration using a novel tissue-engineered, small-caliber
vascular graft without cell seeding
Takenori Yokota, MD, Hajime Ichikawa, MD, PhD, Goro Matsumiya, MD, PhD, Toru Kuratani,
MD, PhD, Taichi Sakaguchi, MD, PhD, Shigemitsu Iwai, MD, PhD, Yukitoshi Shirakawa, MD, PhD,
Kei Torikai, MD, PhD, Atsuhiro Saito, PhD, Eiichiro Uchimura, PhD, Naomasa Kawaguchi, PhD,
Nariaki Matsuura, MD, PhD, and Yoshiki Sawa, MD, PhD, Osaka, Japan
We developed a novel tissue-engineered, biodegradable, small-caliber vascular graft that promotes
autologous tissue regeneration without requiring the pretreatment with cell seeding. The tissue-
engineered vascular grafts showed morphologic evidence of good in situ tissue regeneration and
patency throughout the 12-month postimplantation in a mongrel dog model.
908 Short- and long-term efficacy of aspirin and clopidogrel for
thromboprophylaxis for mechanical heart valves: An in vivo study in swine
Stephen H. McKellar, MD, Jess L. Thompson, III, MD, Raul F. Garcia-Rinaldi, MD,
Ryan J. MacDonald, BS, Thoralf M. Sundt, III, MD, and Hartzell V. Schaff, MD,
Rochester, Minn, and Mayaguez, Puerto Rico
Combination antiplatelet therapy consisting of aspirin and clopidogrel is effective for short- and
long-term thromboprophylaxis of bileaflet mechanical valves in swine.
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Table of Contents (continued)915 The role of temporary biventricular pacing in the cardiac surgical patient with
severely reduced left ventricular systolic function
Rudolph F. Evonich, MD, John C. Stephens, MD, William Merhi, DO, Srinivas Dukkipati, MD,
Nicholas Tepe, MD, Francis Shannon, MD, Jeffrey Altshuler, MD, Marc Sakwa, MD, Joseph Bassett,
MD, Eric Hanson, MD, Judy Boura, MS, William W. O’Neill, MD, and David E. Haines, MD,
Royal Oak, Michigan
Some cardiac surgeons advocate the routine use of temporary atrial synchronous biventricular pacing
for high-risk postoperative patients. The studies supporting this practice are small and
nonrandomized. The current randomized study demonstrates that this practice is not helpful and
may be harmful in some patients.
922 Characterization of the inflammatory cells in ascending thoracic aortic
aneurysms in patients with Marfan syndrome, familial thoracic aortic
aneurysms, and sporadic aneurysms
Rumin He, MD, Dong-Chuan Guo, PhD, Wei Sun, PhD, Christina L. Papke, BS, Senthil Duraisamy,
PhD, Anthony L. Estrera, MD, Hazim J. Safi,MD, Chul Ahn, PhD, L. Maximilian Buja, MD, Frank C.
Arnett, MD, Jingwu Zhang, MD, Yong-Jian Geng, MD, PhD, and Dianna M. Milewicz, MD, PhD,
Houston, Texas
This study sought to investigate the infiltration of T lymphocytes and macrophage in the aortas of
patients with MFS, FTAA, and sporadic TAAs. The results indicate that infiltration of inflammatory
cells contributes to the pathogenesis of TAAs and that superantigen-driven stimulation of
T lymphocytes may contribute to the initial immune response.
930 Interaction between two predictors of functional outcome after
revascularization in ischemic cardiomyopathy: Left ventricular volume
and amount of viable myocardium
Mohammad Hossein Mandegar, MD, Mohammad Ali Yousefnia, MD, Farideh Roshanali, MD,
Hussein Rayatzadeh, MD, and Farshid Alaeddini, MD, PhD, Tehran, Iran
This study investigated the interaction between the left ventricular volume and the amount of viable
myocardium to predict the left ventricular ejection fraction increase after revascularization. Patients
with 6 viable segments showed a good outcome; the left ventricular end-systolic volume played
a major role in the prognosis of those with fewer than 6 viable segments.
937 Is aortic wall degeneration related to bicuspid aortic valve anatomy in patients
with valvular disease?
Claudio F. Russo, MD, Aldo Cannata, MD, Marco Lanfranconi, MD, Ettore Vitali, MD,
Andrea Garatti, MD, and Edgardo Bonacina, MD, Milan, Italy
Patients with bicuspid aortic valve are at increased risk for aortic complications.
943 Stentless valves versus stented bioprostheses at the aortic position:
Midterm results
Sumit Narang, MS, Deepak Kumar Satsangi, MCh, Amit Banerjee, MCh, and Muhammad Abid
Geelani, MCh, New Delhi, India
Stentless vales result in greater improvement in left ventricular function compared with stented
bioprostheses in patients with left ventricular impairment or a small aortic annulus.
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TX948 The transapical approach for aortic valve implantation
Andreas Zierer, MD, Gerhard Wimmer-Greinecker, MD, Sven Martens, MD, Anton Moritz, MD,
and Mirko Doss, MD, Frankfurt/Main, Germany
We report on the initial 26 patients in whom the transapical approach for antegrade placement of
a catheter-deliverable aortic valve was successfully performed at our institution. Initial results are
encouraging, including the absence of permanent neurologic deficits. The transapical approach
provides an attractive alternative to percutaneous aortic valve implantation.
Surgery for Congenital
Heart Disease (CHD)
954 Mitral valve replacement in infants and children 5 years of age or younger:
Evolution in practice and outcome over three decades with a focus on
supra-annular prosthesis implantation
Elif Seda Selamet Tierney, MD, Frank A. Pigula, MD, Charles I. Berul, MD, James E. Lock, MD,
Pedro J. del Nido, MD, and Doff B. McElhinney, MD, Boston, Mass
Among 118 children who underwent mitral valve replacement (MVR) at 5 years of age or younger
from 1976–2006, supra-annular MVR was associated with worse survival than annular MVR in our
recent experience. Patients with supra-annular MVRwere less likely to have operative complete heart
block but remained at risk when the prosthesis was subsequently replaced.
962 Regional differences in tissue oxygenation during cardiopulmonary bypass for
correction of congenital heart disease in neonates and small infants: Relevance
of near-infrared spectroscopy
Mathias Redlin, MD, Andreas Koster, MD, Michael Huebler, MD, Wolfgang Boettcher, ECCP,
Nicole Nagdyman, MD, Roland Hetzer, MD, Hermann Kuppe, MD, and Wolfgang M. Kuebler, MD,
Berlin, Germany
In neonates and small infants with congenital heart disease, regional differences in venous oxygen
saturation and lactate level may lead to systematic overestimation of upper-body oxygenation.
Continuous noninvasive monitoring with near-infrared spectroscopy may assist in early and sensitive
detection of regional malperfusion in such critical organs as the brain.
968 Design and rationale of a randomized trial comparing the Blalock–Taussig and
right ventricle–pulmonary artery shunts in the Norwood procedure
Richard G. Ohye, MD, J. William Gaynor, MD, Nancy S. Ghanayem, MD, Caren S. Goldberg, MD,
MS, Peter C. Laussen, MBBS, Peter C. Frommelt, MD, Jane W. Newburger, MD, MPH, Gail D.
Pearson, MD, ScD, Sarah Tabbutt, MD, PhD, Gil Wernovsky, MD, Lisa M. Wruck, PhD, Andrew M.
Atz, MD, Steve D. Colan, MD, James Jaggers, MD, Brian W. McCrindle, MD, MPH, Ashwin
Prakash, MD, Michael D. Puchalski, MD, Lynn A. Sleeper, ScD, Mario P. Stylianou, PhD, and Lynn
Mahony, MD, for the Pediatric Heart Network Investigators (see Appendix), Ann Arbor, Mich,
Philadelphia, Pa, Milwaukee, Wisconsin, Boston, Mass, Bethesda, Md, Watertown, Mass,
Charleston, SC, Durham, NC, Ontario, Canada, New York, NY, Salt Lake City, Utah, andDallas, Tex
The Pediatric Heart Network designed a randomized clinical trial to compare the modified Blalock–
Taussig and right ventricle–pulmonary artery shunts in the Norwood procedure. This study will make
an important contribution to the management of hypoplastic left heart syndrome and establishes
a model for future surgical trials in congenital heart surgery.
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Table of Contents (continued)976 Two–year survival, mental, and motor outcomes after cardiac extracorporeal
life support at less than five years of age
Laurance Lequier, MD, Ari R. Joffe, MD, Charlene M. T. Robertson, MD, Irina A. Dinu, PhD,
Yuttapong Wongswadiwat, MD, Natalie R. Anton, MD, David B. Ross, MD, and Ivan M. Rebeyka,
MD, for the Western Canadian Complex Pediatric Therapies Program Follow-up Group,
Alberta, Canada, and Khon Kaen, Thailand
Children (n 5 39) having cardiac ECLS were followed up for outcome. Two-year survival was 16
(41%). In survivors, mental score was 736 16. Single ventricle anatomy and admission lactate were
associated with mortality. CPR was not associated with mortality or mental delay. Three variables
explained 77% of the variance in mental outcome.
984 Survival after extracorporeal cardiopulmonary resuscitation in infants
and children with heart disease
Titus Chan, MD, Ravi R. Thiagarajan, MBBS, MPH, Deborah Frank, MD, PhD,
and Susan L. Bratton, MD, MPH, Boston, Mass
We investigated survival and factors associated with mortality for children with heart disease who
were started on extracorporeal membrane oxygenation (ECMO) as an adjunct to conventional
cardiopulmonary resuscitation. Underlying cardiac physiology, complexity of the surgical procedure,
pre-ECMO resuscitation status, and ECMO complications influenced survival to hospital discharge
in this population.
993 Measurement of technical performance in surgery for congenital heart disease:
The stage I Norwood procedure
Emile A. Bacha, MD, Luis A. Larrazabal, MD, Frank A. Pigula, MD, Kimberlee Gauvreau, ScD,
Kathy J. Jenkins, MD, Steve D. Colan, MD, Francis Fynn-Thompson, MD, John E. Mayer, Jr, MD,
and Pedro J. del Nido, MD, Boston, Mass
A technical score was created for the stage I Norwood procedure to evaluate pure technical
performance. The score was validated and correlated with early outcomes.
Evolving Technology (ET) 998 Intraoperative verification of conduction block in atrial fibrillation surgery
Yosuke Ishii, MD, Takashi Nitta, MD, Masaru Kambe, MD, Jiro Kurita, MD, Masami Ochi, MD,
Yasushi Miyauchi, MD, and Kazuo Shimizu, MD, Tokyo, Japan
Incomplete surgical ablation during atrial fibrillation surgery can cause atrial tachycardia
postoperatively. The majority of postoperative atrial tachycardia was associated with an incomplete
coronary sinus ablation. Intraoperative verification of conduction block may prevent the occurrence
of postoperative atrial tachycardia.
1005 Persistent atrial fibrillation in a goat model of chronic left atrial overload
Jan Remes, MD, Thomas J. van Brakel, MD, PhD, Gil Bolotin, MD, PhD, Christian Garber, MD,
Monique M. de Jong, BSc, Frederik H. van der Veen, PhD, and Jos G. Maessen, MD, PhD,
Maastricht, The Netherlands, and Brussel, Belgium
An animal model of left atrial overload induced by an aortic left atrial shunt is described. During a
4-week overload period, progress in atrial dilatation and its electrophysiologic effect were evaluated
in nonanesthetized goats. Persistent atrial fibrillation (.1 week) could be induced.
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TX1012 Evaluation of a new disease-specific endovascular device for type
B aortic dissection
Germano Melissano, MD, Luca Bertoglio, MD, Andrea Kahlberg, MD, Domenico Baccellieri, MD,
MassimilianoM.Marrocco-Trischitta,MD, FabioCalliari,MD, andRobertoChiesa,MD,Milan, Italy
This study evaluates the feasibility, safety, and early technical and clinical success rate of the Zenith
Dissection Endovascular System (William Cook Europe, Bjaerverskov, Denmark), a device recently
available in Europe, for the treatment of type B aortic dissection. Our preliminary results show that the
device can be safely used without affecting the patency of the branches covered by the bare stent.
1019 A novel device for left atrial appendage exclusion: The third-generation atrial
exclusion device
Hideyuki Fumoto, MD, A. Marc Gillinov, MD, Yoshio Ootaki, MD, PhD, Masatoshi Akiyama, MD,
PhD, Diyar Saeed, MD, Tetsuya Horai, MD, Chiyo Ootaki, MD, D. Geoffrey Vince, PhD, Zoran B.
Popovic´, MD, Raymond Dessoffy, AA, Alex Massiello, MEBME, Jacquelyn Catanese, MA, and
Kiyotaka Fukamachi, MD, PhD, Cleveland, Ohio
The third-generation atrial exclusion device achieved easy, reliable, and safe exclusion of the left
atrial appendage with favorable histologic results in dogs. Clinical application could provide a new
therapeutic option for reducing the risk of stroke in patients with atrial fibrillation.
Cardiopulmonary
Support and Physiology
(CSP)
1028 Multimodal evaluation of in vivo magnetic resonance imaging of myocardial
restoration by mouse embryonic stem cells
Stephen L. Hendry, II, MD, Koen E. A. van der Bogt, MS, Ahmad Y. Sheikh, MD, Takayasu Arai, MD,
Scott J. Dylla, PhD, Micha Drukker, PhD, Michael V. McConnell, MD, Ingo Kutschka, MD,
Grant Hoyt, BS, Feng Cao, MD, PhD, Irving L. Weissman, MD, Andrew J. Connolly, MD, PhD,
Marc P. Pelletier, MD, Joseph C. Wu, MD, PhD, Robert C. Robbins, MD, and
Phillip C. Yang, MD, Stanford, Calif, and Leiden, The Netherlands
Multimodal evaluation of the restorative effects of transplanting embryonic stem cells into the
infarcted heart can provide insight into the mechanism of action. Magnetic resonance imaging of
myocardial restoration is correlated with improved functional capacity, robust cell survival, increased
expression of protective genes, and cardiomyogenic differentiation.
1038 Effects of carbamazepine on spinal cord ischemia
Mustafa Sırlak, MD, Sadik Eryılmaz, MD, Mustafa Bahadır Inan, MD, Yusuf Sinan Sırın, DVM,
Omer Besaltı, DVM, PhD, Levent Yazıcıoglu, MD, Evren Ozcınar, MD, Esra Erdemlı, MD,
Refik Tasoz, MD, Atilla Halil Elhan, PhD, Bulent Kaya, MD, and Umit Ozyurda, MD,
Ankara and Samsun, Turkey
This is a randomized controlled study based on a rabbit model showing the protective effects of
carbamazepine on a spinal cord ischemic reperfusion injury.
1044 CCR3- andCXCR4-mediated interactions regulatemigration of CD341 human
bonemarrow progenitors to ischemic myocardium and subsequent tissue repair
N. Bonaros, MD, H. Sondermejer, MD, M. Schuster, PhD, R. Rauf, MD, S. F. Wang, MD, T. Seki,
PhD, D. Skerrett, MD, S. Itescu, MD, and A. A. Kocher, MD, Innsburck, Austria, and New York, NY
This study elucidates the role of CCR3 and CXCR4 chemokine receptors in migration of
hematopoietic progenitors after myocardial infarction. CCR3-dependent chemokine interactions
regulate endogenous migration of CD341 progenitors from bone marrow to ischemic myocardium.
Manipulating CXCR4-dependent interactions could enhance the efficacy of cell therapy after
myocardial infarction.
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TX1054 Platelet activity and aspirin efficacy after off-pump compared with on-pump
coronary artery bypass surgery: Results from the prospective randomized trial
PRAGUE 11–Coronary Artery Bypass and REactivity of Thrombocytes
(CABARET)
Frantisek Bednar, MD, PhD, Pavel Osmancik, MD, PhD, Tomas Vanek, MD, PhD, Heidi Mocikova,
MD, PhD, Martin Jares, MD, Zbynek Straka, MD, PhD, and Petr Widimsky, MD, PhD, FESC,
Prague, Czech Republic
We performed a comparison of early and late platelet activity (P-selectin expression) and aspirin
efficacy (arachidonic acid–induced platelet aggregation) between groups undergoing off-pump and
on-pump coronary artery bypass grafting. In the off-pump group there was significantly higher
platelet activity early after surgical intervention, and in both groups aspirin insufficiency in the
inhibition of platelet aggregation was recorded early after the operation.
Cardiothoracic
Transplantation (TX)
1061 Should lung transplantation be performed using donation after cardiac death?
The United States experience
David P. Mason, MD, Lucy Thuita, MS, Joan M. Alster, MS, Sudish C. Murthy, MD, PhD, Marie M.
Budev, DO, Atul C. Mehta, MD, Go¨sta B. Pettersson, MD, PhD, and Eugene H. Blackstone, MD,
Cleveland, Ohio
Lung transplantation using donation after cardiac death (DCD) can substantially increase the number
of allograft recipients, but widespread acceptance has been slow, and clinical outcomes are uncertain.
Survival after DCD as practiced in the United States is excellent and supports expanded use.
1067 Carbon monoxide–saturated preservation solution protects lung grafts from
ischemia–reperfusion injury
Junichi Kohmoto, MD, Atsunori Nakao, MD, Ryujiro Sugimoto, MD, Yinna Wang, MD,
JiangHua Zhan, MD, Hideo Ueda, PhD, and Kenneth R. McCurry, MD, Pittsburgh, Pa,
and Osaka, Japan
Carbon monoxide (CO) at low concentrations is known to have potent cytoprotective effects. Our
study, using a rat lung transplant model, demonstrated that 5% CO as an additive to the cold flush/
preservation solution can ameliorate cold ischemia–reperfusion injury after prolonged cold
preservation.
Brief Communications:
Technical
1076 Pitfalls in catheter-based interventions to treat paravalvular leaks
Andreas Bairaktaris, MD, Nikolaus A. Haas, MD, Dirk Seifert, MD, Rainer Schaeffler, MD, Heinrich
Koertke, MD, Soren Schenk, MD, and Reiner Koerfer, MD, Bad Oeynhausen, Germany
1077 Resection of a giant thoracic solitary fibrous tumor through two separate
thoracotomies
Chao-Kai Hu, MD, Yih-Leong Chang, MD, Wei-Cheng Lin, MD, and Yung-Chie Lee, MD, PhD,
Taipei, Taiwan
1080 Partial resection of persistent left superior vena cava for a T4 lung cancer
Erdal Okur, MD, Cagatay Tezel, MD, Volkan Baysungur, MD, and Semih Halezerog˘lu, MD,
Istanbul, Turkey
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Clinical
1082 Hypoxemia after an axial flow pump Jarvik-2000 implantation:
Catheter induced
Joonhwa Hong, MD, Soon J. Park, MD, Sunil V. Mankad, MD, Frank Cetta, Jr, MD,
Norman E. Torres, MD, and Morgan L. Brown, MD, Rochester, Minnesota
1084 Aortic root aneurysm in Takayasu arteritis syndrome: Exploration in
active phase and repair in inactive phase
Min-Ho Song, MD, PhD, Tomohiro Nakayama, MD, Keisuke Hattori, MD, Yoshiyuki Tokuda, MD,
Yukio Mabuchi, MD, and Yuichi Ueda, MD, PhD, Gifu and Aichi, Japan
1085 Partial left pulmonary artery sling associated with multiple ventricular septal
defects: A rare congenital anomaly
C. Tissot, MD, J. R. Darst, MD, A. K. Kaza, MD, A. K. Younoszai, MD, and E. da Cruz, MD,
Denver, Colo
1087 Cardiac tamponade secondary to traumatic intrapericardial diaphragmatic
hernia
Affes Nejmeddine, MD, Abdenader Mohamed, MD, Khemakem Khalil, MD, Ben Salah Khalil, MD,
and Beyrouti Mohamed Issam, MD, Sfax, Tunisia
1089 Identification by transesophageal echocardiography of intramural hematoma
and the site of aortic rupture
Kazumasa Orihashi, MD, Taijiro Sueda, MD, Kenji Okada, MD, and Katsuhiko Imai, MD,
Hiroshima, Japan
1091 Aortoesophageal fistula associated with a Kommerell diverticulum and
right-sided aortic arch
Karl G. Reyes, MD, Inderjit S. Gill, MD, Thomas Temes, MD, and Noreen C. Griffin, CNP,
Cleveland, Ohio
1093 Recurrent sarcoma originating from the pulmonary artery 6 years after
extensive thoracic resection
Christine Fegbeutel, MD, Martin Stru¨ber, MD, Jan U. Becker, MD, Florian La¨nger, MD, Nicolas
Dickgreber, MD, Axel Haverich, MD, and Stefan Fischer, MD, MSc, Hannover, Germany
1095 Mitral annuloplasty in an infant with Barth syndrome and severe mitral
insufficiency: First case report and determination of annular diameter
Shu-Chien Huang, MD, En-Ting Wu, MD, Shuenn–Nan Chiu, MD, Wuh-Liang Hwu, MD,
Mei-Hwan Wu, MD, PhD, and Shoei-Shen Wang, MD, PhD, Taipei, Taiwan
Brief Communications:
Research
1098 Pediatric cardiac transplantation: Three-dimensional printing of anatomic
models for surgical planning of heart transplantation in patients with
univentricular heart
Ralf Sodian, MD, Stefan Weber, PhD, Mathias Markert, MSc, Markus Loeff, MD, Tim Lueth, PhD,
Florian C. Weis, MD, Sabine Daebritz, MD, Edward Malec, MD, Christoph Schmitz, MD,
and Bruno Reichart, MD, Munich and Garching, Germany
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TXLetters to the editor 1100 Statins with equivalent lipid-lowering capacity exhibit differential effects on
atrial fibrillation after cardiac surgery
Antonios Kourliouros, MRCS, Neil Roberts, MRCS, and Marjan Jahangiri, FRCS, London, UK
1101 Reply to the Editor
Craig Ian Coleman, PharmD, Storrs, Conn
1101 Box lesion or not—Still unsettled question
Uma N. Srivatsa, MD, Sacramento, CA
1101 Aortic valve replacement dilemma: mechanical or biological prosthesis?
Aldo Cannata, MD, Claudio Francesco Russo, MD, and Corrado Taglieri, MD, Milan, Italy
1102 Reply to the Editor
Morgan Brown, MD, and Hartzell Schaff, MD, Rochester, MN
1102 Importance of stabilization of the mitral annulus in mitral valve repair
Istva´n Szentkira´lyi, MD, A´rpa´d Pe´terffy, MD, PhD, and Zolta´n Galajda, MD, PhD,
Debrecen, Hungary
1103 Reply to the Editor
W. Flameng, MD, PhD, Leuven, Belgium
1103 Questions on the angular (Gothic) arch configuration and its applicability
after type I aortic dissection repair
Frank A. Baciewicz, Jr, MD, Detroit, MI
1104 Aprotinin and renal dysfunction: The role of exposure to angiotensin-converting
enzyme inhibitors
John G. T. Augoustides, MD, FASE, Philadelphia, PA
1104 Reply to the Editor
Domenico Pagano, MD, FRCS, FESC, West Midlands, United Kingdom
1104 Prosthetic valve thrombosis: A regimen of treatment with low-dose and
longer-course using recombinant tissue-type plasminogen activator
is a promising protocol
Fidel Manuel Ca´ceres-Lo´riga, MD, PhD, Horacio Pe´rez-Lo´pez, MD, PhD,
and Karel Morlans-Herna´ndez, MD, Havana, Cuba
1105 Optimizing selective cerebral perfusion in adult aortic arch repair:
Clinical relevance of the laboratory model
John G. T. Augoustides, MD, FASE, Philadelphia, PA
Meeting Proceedings 1107 Highlights from the 11th Annual Scientific Meeting of the International Society
for Minimally Invasive Cardiothoracic Surgery
Lawrence S. Lee, MD, and Jonathan Daniel, MD, Boston, Mass
(continued on page 34A)32A The Journal of Thoracic and Cardiovascular Surgery c October 2008
Table of Contents (continued)
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
TXMeetings and Courses 1110 Meetings and Courses
Announcements The American Association for Thoracic Surgery
1113 Announcement of 2009 Annual Meeting
1113 Preliminary Agenda
1114 Applications for Membership
The Western Thoracic Surgical Association
1114 Announcement of 2009 Annual Meeting
1114 Applications for Membership
The American Board of Thoracic Surgery
1114 Notices
1114 Requirements for Maintenance of Certification
Reader Services 41A JTCVS Disclosure Statement
42A Information for Authors
47A Information for Readers
Earn CME credits at http://cme.ctsnetjournals.org
Supplemental material is available online
Video clip is available online34A The Journal of Thoracic and Cardiovascular Surgery c October 2008
